Department of Cardiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, People's Republic of China.
Mol Med Rep. 2012 Jun;5(6):1491-6. doi: 10.3892/mmr.2012.852. Epub 2012 Mar 30.
Increasing evidence has shown that inflammation is involved in pressure overload-induced cardiac remodeling. Monocyte chemoattractant protein-1 (MCP-1) plays a pivotal role in the inflammatory process. However, the mechanisms underlying the upregulation of MCP-1 expression remain poorly understood. In the present study, we examined the hypothesis that an increased production of reactive oxygen species (ROS) mediates the upregulation of MCP-1. In a pressure-overloaded rat heart model with abdominal aortic coarctation (AC), superoxide dismutase-inhibitable cytochrome C reduction assay showed that ROS generation in the myocardium increased significantly at 1 week by 61% (n=8, P<0.01), peaked at 2 weeks and maintained these high levels for 4 weeks. The elevation of ROS was paralleled by the increased expression of MCP-1 and left ventricular remodeling (cardiac hypertrophy, perivascular and interstitial fibrosis). The oral administration of the antioxidant, N-acetylcysteine (NAC, 0.2 g/kg/day), for 2 or 4 weeks, significantly attenuated ROS production by 69 and 68%, respectively (n=8, P<0.01), as well as left ventricular remodeling. NAC treatment for 2 weeks also significantly reduced the MCP-1 mRNA and protein levels by 52 and 60%, respectively (n=4-8, both P<0.01), but had no effect on blood pressure. In the rats with AC at 2 weeks, when MCP-1 expression and inflammation changes were overt, immunoblotting with phospho-specific antibodies revealed that extracellular regulated kinase (ERK) and c-jun NH2-terminal kinase (JNK), but not p38 mitogen-activated protein kinase, were activated. NAC administration attenuated JNK activation, but had no effect on ERK. Our results suggest that increased ROS production may play an important role in the increased expression of MCP-1 in pressure overload-induced cardiac remodeling. JNK is likely involved in the signaling pathway.
越来越多的证据表明,炎症参与了压力超负荷引起的心脏重构。单核细胞趋化蛋白-1(MCP-1)在炎症过程中起着关键作用。然而,MCP-1 表达上调的机制仍知之甚少。在本研究中,我们检验了这样一个假设,即活性氧(ROS)的产生增加介导了 MCP-1 的上调。在腹主动脉缩窄(AC)的压力超负荷大鼠心脏模型中,超氧化物歧化酶抑制的细胞色素 C 还原测定显示,心肌中 ROS 的产生在 1 周时显著增加了 61%(n=8,P<0.01),在 2 周时达到峰值,并维持 4 周的高水平。ROS 的升高与 MCP-1 的表达增加和左心室重构(心肌肥厚、血管周围和间质纤维化)平行。口服抗氧化剂 N-乙酰半胱氨酸(NAC,0.2 g/kg/天)2 或 4 周,分别显著抑制 ROS 产生 69%和 68%(n=8,P<0.01),以及左心室重构。NAC 治疗 2 周还分别显著降低了 MCP-1 mRNA 和蛋白水平 52%和 60%(n=4-8,均 P<0.01),但对血压无影响。在 2 周 AC 的大鼠中,当 MCP-1 表达和炎症变化明显时,用磷酸化特异性抗体进行免疫印迹显示,细胞外调节激酶(ERK)和 c-jun NH2-末端激酶(JNK),而不是 p38 丝裂原活化蛋白激酶,被激活。NAC 给药抑制 JNK 激活,但对 ERK 没有影响。我们的结果表明,ROS 产生的增加可能在压力超负荷引起的心脏重构中 MCP-1 表达增加中起重要作用。JNK 可能参与了信号通路。